<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We measured plasma markers of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, <z:mp ids='MP_0001863'>vascular inflammation</z:mp>, and pro-coagulation in <z:mp ids='MP_0001261'>obese</z:mp> Hispanic/Latino children and adolescents with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance and determined their relationship to body composition and indexes of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 38 lean or <z:mp ids='MP_0001261'>obese</z:mp> Hispanic children and adolescents (10-18 years of age) were selected </plain></SENT>
<SENT sid="2" pm="."><plain>The overweight group (n = 21) had a BMI &gt;85th percentile for their age and sex, and the lean group (n = 17) had a BMI between the 25th and 50th percentiles </plain></SENT>
<SENT sid="3" pm="."><plain>Studies included an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test, measurements of plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipids</z:chebi>, several markers of endothelial function and <z:mp ids='MP_0001845'>inflammation</z:mp>, and determination of body composition by dual X-ray absorptiometry </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The <z:mp ids='MP_0001261'>obese</z:mp> group had higher systolic blood pressure and plasma <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and was more insulin resistant than the lean group </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:mp ids='MP_0001261'>obese</z:mp> group also had higher plasma soluble intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (259.5 +/- 60.0 vs. 223.2 +/- 47.5 ng/ml, P = 0.047), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (2.57 +/- 1.1 vs. 1.74 +/- 0.6 pg/ml, P = 0.008), high-sensitivity C-reactive protein (2.0 vs. 0.13 mg/l, P &lt; 0.0001), plasminogen-activated inhibitor-1 (47.0 +/- 35.7 vs. 12.0 +/- 5.2 ng/ml, P &lt; 0.0001), tissue plasminogen activator (6.1 +/- 1.9 vs. 4.1 +/- 0.8 ng/ml, P = 0.001), and white blood cell count (6.9 vs. 5.3 x 10(3), P = 0.031) and lower levels of adiponectin (8.7 +/- 3.3 vs. 12.6 +/- 5.2 microg/ml, P = 0.022) </plain></SENT>
<SENT sid="6" pm="."><plain>No significant differences were observed for soluble vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule or interleukin-6 </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Overweight Hispanic children and adolescents with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance exhibit increased plasma markers of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> and subclinical <z:mp ids='MP_0001845'>inflammation</z:mp> in association with <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>These abnormalities may predispose them to the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
</text></document>